Inflammation-induced alterations in central nervous system (CNS) metabolism have focused on glutamate. At excessive concentrations, glutamate is toxic to glia and neurons, and inflammatory cytokines have been shown to influence glutamate turnover by blocking glutamate reuptake and increasing glutamate release. Increased glutamate has also been found in depression, a disorder associated with increased inflammation. Data by our group have shown increased glutamate as measured by magnetic resonance spectroscopy (MRS) in basal ganglia and dorsal anterior cingulate cortex of patients administered the inflammatory cytokine interferon (IFN)-alpha. Given data that increasing age is associated with an exaggerated CNS inflammatory response, we examined whether older age (>55 years) would be associated with a greater IFN-alpha-induced increase in CNS glutamate. Using a longitudinal design, 31 patients with hepatitis C virus (HCV) underwent MRS, blood sampling for inflammatory markers, and behavioral assessments before (Visit 1) and after 4 weeks (Visit 2) of either IFN-alpha (n = 17) or no treatment (n = 14). Older patients treated with IFN-alpha exhibited a significantly greater increase in glutamate from Visit 1 to Visit 2 as reflected by the glutamate/creatine ratio (Glu/Cr) in left basal ganglia compared to older controls and younger IFN-alpha-treated and untreated subjects. In addition, increased Glu/Cr in older but not younger IFN-alpha-treated and untreated patients was associated with increased tumor necrosis factor, reduced motivation as measured by the Multidimensional Fatigue Inventory and increased choice movement time on the Cambridge Neuropsychological Test Automated Battery. Taken together, these preliminary data support the notion that older age may interact with inflammation to exaggerate the effects of inflammatory stimuli on CNS glutamate and behavior.
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Introduction
Patients exposed to the inflammatory cytokine interferon (IFN)-alpha were found to exhibit increased glutamate in left basal ganglia and dorsal anterior cingulate cortex (dACC) as determined by single voxel magnetic resonance spectroscopy (MRS) (Haroon et al., 2014) . Increased glutamate was in turn correlated with depressive symptoms. These data are consistent with increased CNS glutamate in bipolar and some unipolar depression (Yuksel and Ongur, 2010) , both of which exhibit increased inflammatory markers (Miller et al., 2009) .
Regarding mechanisms by which inflammation may increase CNS glutamate, inflammatory cytokines can decrease expression of glutamate transporters on astrocytes, resulting in decreased glutamate reuptake (Tilleux and Hermans, 2007) , and stimulate astrocytic glutamate release (Malarkey and Parpura, 2008) . Moreover, inflammatory cytokines can activate indoleamine 2,3 dioxygenase (IDO), an enzyme which catabolizes tryptophan into kynurenine that in turn can be converted into quinolinic acid (Miller et al., 2009) . Quinolinic acid is an agonist at glutamate receptors and can also stimulate glutamate release while inhibiting astrocytic glutamate reuptake (Miller et al., 2009; Savitz et al., 2014; Tavares et al., 2002) . At high concentrations, extracellular glutamate is toxic to both neurons and glia. However, it should be noted that current MRS methodology is limited in discriminating extra-versus
